Skip to content

The safety and feasibility of the application of the strategy along vagus nerve and phrenic nerve chain in the systematic lymph node dissection for NSCLC patients

The safety and feasibility of the application of the strategy along vagus nerve and phrenic nerve chain in the systematic lymph node dissection for NSCLC patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018461
Enrollment
Unknown
Registered
2018-09-20
Start date
2018-09-20
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSCLC

Interventions

Case series:thoracoscopic lung cancer radical surgery with the strategy along the vagus nerve and phrenic nerve chain in systemic lymph node dissection

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. No neoadjuvant chemoradiation before surgery; 2. Planned thoracoscopic radical resection of lung cancer with intraoperative hihar and mediastinal lymph nodes dissection along the vagus nerve and phrenic nerve chain; 3. Intraoperatie and/or postoperative histopathology confirmed as R0 resected non-small cell lung cancer (NSCLC); 4. Obtain informed consent signed by the patient or his legal representative; 5. Patients compliance is good; 6. Men or women aged 18 to 75 years old; 7. ECOG behavior status score 0~1.

Exclusion criteria

Exclusion criteria: 1. Have cancer other than NSCLC within five years prior to the study; 2. Known human immunodeficiency virus (HIV) infection; 3. With small cell lung cancer components; 4. Pregnant or lactating women; 5. Have a clear history of neurological or mental disorders, including epilepsy or dementia; 6. Other situations investigators believe that it is not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
postoperative pathological N-stage up-regulation rate;postoperative quality of life;

Secondary

MeasureTime frame
Vagus nerve injury score;Phrenic nerve injury score;the number of lymph node dissection groups and the number of dissected lymph node;Perioperative complications;

Countries

China

Contacts

Public ContactCheng Chao

The First Affiliated Hospital of Sun Yat-sen University

drchengchao@163.com+86 13710763975

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026